Literature DB >> 23595883

Dominant effects of the Huntington's disease HTT CAG repeat length are captured in gene-expression data sets by a continuous analysis mathematical modeling strategy.

Jong-Min Lee1, Ekaterina I Galkina, Rachel M Levantovsky, Elisa Fossale, Mary Anne Anderson, Tammy Gillis, Jayalakshmi Srinidhi Mysore, Kathryn R Coser, Toshi Shioda, Bin Zhang, Matthew D Furia, Jonathan Derry, Isaac S Kohane, Ihn Sik Seong, Vanessa C Wheeler, James F Gusella, Marcy E MacDonald.   

Abstract

In Huntington's disease (HD), the size of the expanded HTT CAG repeat mutation is the primary driver of the processes that determine age at onset of motor symptoms. However, correlation of cellular biochemical parameters also extends across the normal repeat range, supporting the view that the CAG repeat represents a functional polymorphism with dominant effects determined by the longer allele. A central challenge to defining the functional consequences of this single polymorphism is the difficulty of distinguishing its subtle effects from the multitude of other sources of biological variation. We demonstrate that an analytical approach based upon continuous correlation with CAG size was able to capture the modest (∼21%) contribution of the repeat to the variation in genome-wide gene expression in 107 lymphoblastoid cell lines, with alleles ranging from 15 to 92 CAGs. Furthermore, a mathematical model from an iterative strategy yielded predicted CAG repeat lengths that were significantly positively correlated with true CAG allele size and negatively correlated with age at onset of motor symptoms. Genes negatively correlated with repeat size were also enriched in a set of genes whose expression were CAG-correlated in human HD cerebellum. These findings both reveal the relatively small, but detectable impact of variation in the CAG allele in global data in these peripheral cells and provide a strategy for building multi-dimensional data-driven models of the biological network that drives the HD disease process by continuous analysis across allelic panels of neuronal cells vulnerable to the dominant effects of the HTT CAG repeat.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23595883      PMCID: PMC3723309          DOI: 10.1093/hmg/ddt176

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  35 in total

Review 1.  Comparison of ARM and HEAT protein repeats.

Authors:  M A Andrade; C Petosa; S I O'Donoghue; C W Müller; P Bork
Journal:  J Mol Biol       Date:  2001-05-25       Impact factor: 5.469

2.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias.

Authors:  B M Bolstad; R A Irizarry; M Astrand; T P Speed
Journal:  Bioinformatics       Date:  2003-01-22       Impact factor: 6.937

3.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

Authors: 
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

4.  Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects.

Authors:  Ruth Luthi-Carter; Andrew D Strand; Sarah A Hanson; Charles Kooperberg; Gabriele Schilling; Albert R La Spada; Diane E Merry; Anne B Young; Christopher A Ross; David R Borchelt; James M Olson
Journal:  Hum Mol Genet       Date:  2002-08-15       Impact factor: 6.150

5.  Increased rate of suicide among patients with Huntington's disease.

Authors:  M Schoenfeld; R H Myers; L A Cupples; B Berkman; D S Sax; E Clark
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-12       Impact factor: 10.154

6.  A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntington's disease chromosomes.

Authors:  J P Warner; L H Barron; D J Brock
Journal:  Mol Cell Probes       Date:  1993-06       Impact factor: 2.365

7.  Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset.

Authors:  Nancy S Wexler; Judith Lorimer; Julie Porter; Fidela Gomez; Carol Moskowitz; Edith Shackell; Karen Marder; Graciela Penchaszadeh; Simone A Roberts; Javier Gayán; Denise Brocklebank; Stacey S Cherny; Lon R Cardon; Jacqueline Gray; Stephen R Dlouhy; Sandra Wiktorski; Marion E Hodes; P Michael Conneally; Jack B Penney; James Gusella; Jang-Ho Cha; Michael Irizarry; Diana Rosas; Steven Hersch; Zane Hollingsworth; Marcy MacDonald; Anne B Young; J Michael Andresen; David E Housman; Margot Mieja De Young; Ernesto Bonilla; Theresa Stillings; Americo Negrette; S Robert Snodgrass; Maria Dolores Martinez-Jaurrieta; Maria A Ramos-Arroyo; Jacqueline Bickham; Juan Sanchez Ramos; Frederick Marshall; Ira Shoulson; Gustavo J Rey; Andrew Feigin; Norman Arnheim; Amarilis Acevedo-Cruz; Leticia Acosta; Jose Alvir; Kenneth Fischbeck; Leslie M Thompson; Angela Young; Leon Dure; Christopher J O'Brien; Jane Paulsen; Adam Brickman; Denise Krch; Shelley Peery; Penelope Hogarth; Donald S Higgins; Bernhard Landwehrmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-01       Impact factor: 11.205

8.  A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length.

Authors:  D R Langbehn; R R Brinkman; D Falush; J S Paulsen; M R Hayden
Journal:  Clin Genet       Date:  2004-04       Impact factor: 4.438

9.  CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion.

Authors:  J-M Lee; E M Ramos; J-H Lee; T Gillis; J S Mysore; M R Hayden; S C Warby; P Morrison; M Nance; C A Ross; R L Margolis; F Squitieri; S Orobello; S Di Donato; E Gomez-Tortosa; C Ayuso; O Suchowersky; R J A Trent; E McCusker; A Novelletto; M Frontali; R Jones; T Ashizawa; S Frank; M H Saint-Hilaire; S M Hersch; H D Rosas; D Lucente; M B Harrison; A Zanko; R K Abramson; K Marder; J Sequeiros; J S Paulsen; G B Landwehrmeyer; R H Myers; M E MacDonald; J F Gusella
Journal:  Neurology       Date:  2012-02-08       Impact factor: 9.910

10.  The predominantly HEAT-like motif structure of huntingtin and its association and coincident nuclear entry with dorsal, an NF-kB/Rel/dorsal family transcription factor.

Authors:  Hiroki Takano; James F Gusella
Journal:  BMC Neurosci       Date:  2002-10-14       Impact factor: 3.288

View more
  14 in total

1.  Sex-specific effects of the Huntington gene on normal neurodevelopment.

Authors:  Jessica K Lee; Yue Ding; Amy L Conrad; Elena Cattaneo; Eric Epping; Kathy Mathews; Pedro Gonzalez-Alegre; Larry Cahill; Vincent Magnotta; Bradley L Schlaggar; Joel S Perlmutter; Regina E Y Kim; Jeffrey D Dawson; Peg Nopoulos
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

2.  Small interfering RNAs based on huntingtin trinucleotide repeats are highly toxic to cancer cells.

Authors:  Andrea E Murmann; Quan Q Gao; William E Putzbach; Monal Patel; Elizabeth T Bartom; Calvin Y Law; Bryan Bridgeman; Siquan Chen; Kaylin M McMahon; C Shad Thaxton; Marcus E Peter
Journal:  EMBO Rep       Date:  2018-02-12       Impact factor: 8.807

3.  Novel allele-specific quantification methods reveal no effects of adult onset CAG repeats on HTT mRNA and protein levels.

Authors:  Aram Shin; Baehyun Shin; Jun Wan Shin; Kyung-Hee Kim; Ranjit S Atwal; Jennifer M Hope; Tammy Gillis; John D Leszyk; Scott A Shaffer; Ramee Lee; Seung Kwak; Marcy E MacDonald; James F Gusella; Ihn Sik Seong; Jong-Min Lee
Journal:  Hum Mol Genet       Date:  2017-04-01       Impact factor: 6.150

4.  Ablation of huntingtin in adult neurons is nondeleterious but its depletion in young mice causes acute pancreatitis.

Authors:  Guohao Wang; Xudong Liu; Marta A Gaertig; Shihua Li; Xiao-Jiang Li
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-07       Impact factor: 11.205

Review 5.  Invited review: decoding the pathophysiological mechanisms that underlie RNA dysregulation in neurodegenerative disorders: a review of the current state of the art.

Authors:  Matthew J Walsh; Johnathan Cooper-Knock; Jennifer E Dodd; Matthew J Stopford; Simeon R Mihaylov; Janine Kirby; Pamela J Shaw; Guillaume M Hautbergue
Journal:  Neuropathol Appl Neurobiol       Date:  2015-02       Impact factor: 8.090

6.  Making (anti-) sense out of huntingtin levels in Huntington disease.

Authors:  Melvin M Evers; Menno H Schut; Barry A Pepers; Melek Atalar; Martine J van Belzen; Richard Lm Faull; Raymund Ac Roos; Willeke M C van Roon-Mom
Journal:  Mol Neurodegener       Date:  2015-04-28       Impact factor: 14.195

7.  HD CAGnome: a search tool for huntingtin CAG repeat length-correlated genes.

Authors:  Ekaterina I Galkina; Aram Shin; Kathryn R Coser; Toshi Shioda; Isaac S Kohane; Ihn Sik Seong; Vanessa C Wheeler; James F Gusella; Marcy E Macdonald; Jong-Min Lee
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

Review 8.  Transcription, epigenetics and ameliorative strategies in Huntington's Disease: a genome-wide perspective.

Authors:  Luis M Valor
Journal:  Mol Neurobiol       Date:  2014-05-01       Impact factor: 5.590

Review 9.  Optical Coherence Tomography in Alzheimer's Disease and Other Neurodegenerative Diseases.

Authors:  Jonah Doustar; Tania Torbati; Keith L Black; Yosef Koronyo; Maya Koronyo-Hamaoui
Journal:  Front Neurol       Date:  2017-12-19       Impact factor: 4.003

10.  Population-specific genetic modification of Huntington's disease in Venezuela.

Authors:  Michael J Chao; Kyung-Hee Kim; Jun Wan Shin; Diane Lucente; Vanessa C Wheeler; Hong Li; Jared C Roach; Leroy Hood; Nancy S Wexler; Laura B Jardim; Peter Holmans; Lesley Jones; Michael Orth; Seung Kwak; Marcy E MacDonald; James F Gusella; Jong-Min Lee
Journal:  PLoS Genet       Date:  2018-05-11       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.